REFERENCES
1. Liu, H.; Yin, P.; Qi, J.; Zhou, M. Burden of non-communicable diseases in China and its provinces, 1990-2021: results from the Global Burden of Disease Study 2021. Chin. Med. J. 137, 2325-33 (2024).
2. Wu, Q. et al. A U-shaped association between dietary phosphorus intake and new-onset hypertension: a nationwide cohort study in China. Am. Heart J. 259, 21-9 (2023).
3. Wu, Q. et al. A U-shaped association between dietary phosphorus intake and new-onset diabetes: a nationwide cohort study in China. Nutr. Metab. Cardiovasc. Dis. 33, 1932-40 (2023).
4. He, P. et al. J-shaped association between dietary zinc intake and new-onset hypertension: a nationwide cohort study in China. Front. Med. 17, 156-64 (2022).
5. He, P. U-shaped association between dietary zinc intake and new-onset diabetes: a nationwide cohort study in China. J. Clin. Endocrinol. Metab. 107, e815-24 (2022).
6. Yang, S. et al. PURE healthy diet score, genetic susceptibility, and incident chronic kidney disease. Food Funct. 16, 8827-35 (2025).
7. Zhang, Y. et al. Pro-inflammatory and pro-oxidant diets and CKD risk across cardiovascular-kidney-metabolic syndrome stages: a multi-omics mediation analysis. Food Funct. 17, 449-60 (2026).
8. Liu, M. et al. Evaluation of the association between coffee consumption, including type (instant, ground), and addition of milk or sweeteners and new-onset hypertension and potential modifiers. J. Acad. Nutr. Diet. 125, 641-653.e10 (2025).
9. Ye, Z. et al. Coffee consumption with different additives and types, genetic variation in caffeine metabolism and new-onset acute kidney injury. Br. J. Nutr. 132, 1645-53 (2024).
10. Xiang, H. et al. Tea consumption, milk or sweeteners addition, genetic variation in caffeine metabolism, and incident venous thromboembolism. Thromb. Haemost. 124, 1143-51 (2024).
11. Gan, X. et al. Habitual fish oil supplementation, genetic susceptibility of kidney stones and the risk of new-onset kidney stones. J. Clin. Lipidol. 18, e116-24 (2024).
12. Liu, M. et al. Habitual fish oil supplementation and incident chronic kidney disease in the UK biobank. Nutrients 15, 22 (2022).
13. Yang, S. et al. Plasma metabolites mediate the association of total and specific fruit intake with incident chronic kidney disease risk. Food Funct. 16, 6612-21 (2025).
14. Gan, X. et al. Association of quantity and diversity of different types of fruit intake with new-onset kidney stones. Mol. Nutr. Food Res. 68, 2400373 (2024).
15. Liu, M. et al. Relationship of ultra-processed food consumption and new-onset chronic kidney diseases among participants with or without diabetes. Diabetes Metab. 49, 101456 (2023).
16. Liu, M. et al. Adding salt to foods and hazards of microvascular, cerebrovascular and cardiovascular diseases. Eur. J. Clin. Nutr. 78, 141-8 (2023).
17. Wei, Y. et al. Quantity and variety of food groups consumption and the risk of hypertension in adults: a prospective cohort study. Hypertens. Res. 48, 971-82 (2024).
18. Liu, M. et al. Quantity and variety of food groups consumption and the risk of diabetes in adults: a prospective cohort study. Clin. Nutr. 40, 5710-7 (2021).
19. Zhou, C. et al. Inverse association between variety of proteins with appropriate quantity from different food sources and new-onset hypertension. Hypertension 79, 1017-27 (2022).
20. Zhou, C. et al. Variety and quantity of dietary protein intake from different sources and risk of new-onset diabetes: a Nationwide Cohort Study in China. BMC Med. 20, 6 (2022).
21. Zhou, C. et al. Relationship of different sourced protein intake, quantity of plasma amino acid with chronic kidney disease. J. Nutr. 155, 1165-72 (2025).
22. Ye, Z. et al. Variety and quantity of dietary insoluble fiber intake from different sources and risk of new-onset hypertension. BMC Med. 21, 61 (2023).
23. Yang, S. et al. Variety and quantity of dietary-insoluble fiber intake from different sources and risk of new-onset diabetes. J. Clin. Endocrinol. Metab. 108, 175-83 (2023).
24. Zhou, C. et al. Dietary carbohydrate intake and new-onset diabetes: a nationwide cohort study in China. Metabolism 123, 154865 (2021).
25. Li, Q. et al. Dietary carbohydrate intake and new-onset hypertension: a nationwide cohort study in China. Hypertension 78, 422-30 (2021).
26. Liu, C. et al. Dietary low- and high-quality carbohydrate intake and cognitive decline: a prospective cohort study in older adults. Clin. Nutr. 42, 1322-9 (2023).
27. Liu, M. et al. Relationship of dietary intake of food folate and synthetic folic acid intake from fortified foods with all-cause mortality in individuals with chronic kidney disease. Food Funct. 15, 559-68 (2024).
28. Li, Y.; Spence, J. D.; Wang, X.; Huo, Y.; Xu, X.; Qin, X. Effect of vitamin B12 levels on the association between folic acid treatment and CKD progression: a post hoc analysis of a folic acid interventional trial. Am. J. Kidney Dis. 75, 325-32 (2020).
29. Alam, C.; Hoque, M. T.; Finnell, R. H.; Goldman, I. D.; Bendayan, R. Regulation of reduced folate carrier (RFC) by vitamin D receptor at the blood-brain barrier. Mol. Pharm. 14, 3848-58 (2017).
30. Wang, L. et al. Vitamin D, folic acid and vitamin B12 can reverse vitamin D deficiency-induced learning and memory impairment by altering 27-hydroxycholesterol and S-adenosylmethionine. Nutrients 15, 132 (2022).
31. Zhang, Y. et al. Dietary vitamin E intake and new-onset hypertension. Hypertens. Res. 46, 1267-75 (2023).
32. He, P. et al. Evaluation of plasma vitamin E and development of proteinuria in hypertensive patients. J. Transl. Int. Med. 12, 78-85 (2024).
33. Zhang, Y. et al. Dietary vitamin E and tocopherol isoforms and incident chronic kidney disease: a 30-y follow-up study from young adulthood to midlife. Free Radic. Biol. Med. 190, 284-91 (2022).
34. Zhang, Y. et al. Dietary vitamin E and tocopherol isoform intake and the progression of chronic kidney disease. Nephrol. Dial. Transplant. 40, 1854-64 (2025).
35. Song, Y. et al. Plasma vitamin E and the risk of first stroke in hypertensive patients: a nested case-control study. Front. Nutr. 8, 734580 (2021).
36. >Wang, J. et al. A Nested case-control study on plasma vitamin E and risk of cancer: evidence of effect modification by selenium. J. Acad. Nutr. Diet. 119, 769-81 (2019).
37. Zhang, Y. et al. Inverse association between dietary vitamin A intake and new-onset hypertension. Clin. Nutr. 40, 2868-75 (2021).
38. Li, H. et al. Association between plasma retinol levels and the risk of all-cause mortality in general hypertensive patients: a nested case-control study. J. Clin. Hypertens. 22, 906-13 (2020).
39. Xie, L. et al. Association of plasma retinol levels with incident cancer risk in Chinese hypertensive adults: a nested case-control study. Br. J. Nutr. 122, 293-300 (2019).
40. Yu, Y. et al. Plasma retinol and the risk of first stroke in hypertensive adults: a nested case-control study. Am. J. Clin. Nutr. 109, 449-56 (2019).
41. Zhang, Y. et al. U-shaped relation of dietary thiamine intake and new-onset hypertension. Nutrients 14, 3251 (2022).
42. Liu, C. et al. J-shaped association between dietary thiamine intake and the risk of cognitive decline in cognitively healthy, older Chinese individuals. Gen. Psychiatr. 37, e101311 (2024).
43. Liu, M. et al. Inverse association between riboflavin intake and new-onset hypertension: a nationwide cohort study in China. Hypertension 76, 1709-16 (2020).
44. Zhang, Z. et al. Evaluation of dietary niacin and new-onset hypertension among Chinese adults. JAMA Netw. Open 4, e2031669 (2021).
45. Zhou, C. et al. Relationships of serum 25-hydroxyvitamin D concentrations, diabetes, genetic susceptibility, and new-onset chronic kidney disease. Diabetes Car 45, 2518-25 (2022).
46. Zhang, Y. et al. Serum 25-hydroxyvitamin D, genetic susceptibility, and abdominal aortic aneurysm risk. J. Clin. Endocrinol. Metab. 110, 1989-96 (2025).
47. Zhou, C. et al. Relationship among serum 25-hydroxyvitamin D, fibrosis stage, genetic susceptibility, and risk of severe liver disease. Nutrition 119, 112320 (2024).
48. Zhou, C. et al. Serum 25-hydroxyvitamin D, vitamin D receptor, and vitamin-D-binding protein gene polymorphisms and risk of dementia among older adults with prediabetes. J. Gerontol. A Biol. Sci. Med. Sci. 79, glae015 (2024).
49. Zhang, Y. et al. Relationship of serum 25-hydroxyvitamin D, obesity with new-onset obstructive sleep apnea. Int. J. Obes. 48, 218-23 (2024).
50. Lin, T. et al. Plasma 25-hydroxyvitamin D concentrations and risk of incident cancer in adults with hypertension: a nested case-control study. Clin. Nutr. 38, 2381-8 (2019).
51. Xiang, H. et al. Relationship of serum 25-hydroxyvitamin D concentrations, diabetes, vitamin D receptor gene polymorphisms and incident venous thromboembolism. Diabetes Metab. Res. Rev. 41, e70014 (2024).
52. Zhou, C. et al. Associations between serum 25-hydroxyvitamin D, sun exposure time, dietary vitamin D intake, and new-onset acute kidney injury among 413,169 UK adults. J. Nutr. 153, 713-22 (2023).
53. Zhou, H. et al. Plasma 25-hydroxyvitamin D3 concentrations and risk of new-onset proteinuria in patients with hypertension. J. Ren. Nutr. 31, 620-7 (2021).
54. He, P. et al. Prospective association between baseline plasma zinc concentration and development of proteinuria in Chinese hypertensive patients. J. Trace Elem. Med. Biol. 66, 126755 (2021).
55. Zhang, J. et al. Baseline plasma zinc and risk of first stroke in hypertensive patients: a nested case-control study. Stroke 50, 3255-8 (2019).
56. Meng, Q. et al. L-shaped association between dietary zinc intake and cognitive decline in Chinese older people. Age Ageing 53, afae008 (2024).
57. Zhang, Y. et al. U-shaped association between dietary copper intake and new-onset chronic kidney disease: a 30-year follow-up study from young adulthood to midlife. Mol. Nutr. Food Res. 69, e202400761 (2025).
58. He, P. et al. U-shaped association between dietary copper intake and new-onset hypertension. Clin. Nutr. 41, 536-42 (2022).
59. Gan, X. et al. J-shaped association between dietary copper intake and all-cause mortality: a prospective cohort study in Chinese adults. Br. J. Nutr. 129, 1841-7 (2022).
60. Meng, Q. et al. Association between dietary copper intake and cognitive decline: a perspective cohort study in Chinese elderly. Am. J. Geriatr. Psychiatry 31, 753-63 (2023).
61. Zhang, J. et al. Plasma copper and the risk of first stroke in hypertensive patients: a nested case-control study. Am. J. Clin. Nutr. 110, 212-20 (2019).
62. Cao, J. et al. Serum phosphate and the risk of new-onset hyperuricemia in hypertensive patients. Hypertension 74, 102-10 (2019).
63. Wang, Z. et al. Plasma selenium and the risk of first stroke in adults with hypertension: a secondary analysis of the China Stroke Primary Prevention Trial. Am. J. Clin. Nutr. 115, 222-31 (2022).
64. Wang, Z. et al. Association between plasma selenium and risk of ischemic stroke: a community-based, nested, and case-control study. Front. Nutr. 9, 1001922 (2022).
65. Zhang, Y. et al. Plasma selenium levels and risk of new-onset diabetes in hypertensive adults. J. Trace Elem. Med. Biol. 56, 6-12 (2019).
66. Zhang, Y. et al. Positive association between dietary manganese intake and new-onset hypertension: a nationwide cohort study in China. Nutr. Metab. Cardiovasc. Dis. 34, 699-705 (2024).
67. Huang, Y. et al. Association of dietary manganese intake with new-onset chronic kidney disease in participants with diabetes. Diabetes Metab. Syndr. 18, 103138 (2024).
68. Huang, Y. et al. Association and pathways between dietary manganese intake and incident venous thromboembolism. Thromb. Haemostasis 124, 546-54 (2024).
69. Lin, T. et al. Plasma magnesium concentrations and risk of incident cancer in adults with hypertension: a nested case-control study. Ann. Nutr. Metab. 76, 304-12 (2020).
70. Cao, J. et al. Plasma magnesium and the risk of new-onset hyperuricaemia in hypertensive patients. Br. J. Nutr. 124, 156-63 (2020).
71. Zhang, Z. et al. Dietary iron intake and new-onset hypertension: a nationwide cohort study from China. J. Nutr. Health Aging 26, 1016-24 (2022).
72. He, Q.; Li, J. The evolution of folate supplementation - from one size for all to personalized, precision, poly-paths. J. Transl. Int. Med. 11, 128-37 (2023).
73. U.S. Department of Health and Human Services, U.S. Department of Agriculture. Dietary Guidelines for Americans, 2025-2030. https://cdn.realfood.gov/DGA.pdf (accessed 2026-05-27).
74. Chen, P. et al. A sensitive UPLC-MS/MS method for simultaneous quantification of one-carbon metabolites & co-factors in human plasma. J. Pharm. Biomed. Anal. 219, 114944 (2022).
75. Huang, X. et al.; Precision Folic Acid Trial to lower homocysteine (PFAT-Hcy) Trial Investigators. Optimal folic acid dosage in lowering homocysteine: Precision Folic Acid Trial to lower homocysteine (PFAT-Hcy). Eur. J. Nutr. 63, 1513-28 (2024).
76. Huang, L. W.; Li, L. L.; Li, J.; Chen, X. R.; Yu, M. Association of the methylenetetrahydrofolate reductase (MTHFR) gene variant C677T with serum homocysteine levels and the severity of ischaemic stroke: a case-control study in the southwest of China. J. Int. Med. Res. 50, 03000605221081632 (2022).
77. Qin, X. et al. MTHFR C677T and MTR A2756G polymorphisms and the homocysteine lowering efficacy of different doses of folic acid in hypertensive Chinese adults. Nutr. J. 11, 2 (2012).
78. Wijerathne, C. U. B.; Au-Yeung, K. K. W.; Siow, Y. L.; O, K. 5-methyltetrahydrofolate attenuates oxidative stress and improves kidney function in acute kidney injury through activation of Nrf2 and antioxidant defense. Antioxidants 11, 1046 (2022).
79. Rezk, B. M.; Haenen, G. R.; van der Vijgh, W. J.; Bast, A. Tetrahydrofolate and 5-methyltetrahydrofolate are folates with high antioxidant activity. Identification of the antioxidant pharmacophore. FEBS Lett. 555, 601-5 (2003).
80. Buccianti, G. et al. 5-methyltetrahydrofolate restores endothelial function in uraemic patients on convective haemodialysis. Nephrol. Dial. Transplant. 17, 857-64 (2002).
81. Zhang, T. et al. Cost-effectiveness of folic acid therapy for primary prevention of stroke in patients with hypertension. BMC Med. 20, 407 (2022).
